Future of Dendritic Cell-Based Approaches in Pancreatic Cancer.
作者信息
Somasundaram Ashwin, Yeh Jen Jen
机构信息
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Department of Medicine, University of North Carolina, Chapel Hill, NC.
出版信息
J Clin Oncol. 2024 Sep 10;42(26):3067-3070. doi: 10.1200/JCO.24.00846. Epub 2024 Jul 11.
Abstract
摘要
相似文献
1
Future of Dendritic Cell-Based Approaches in Pancreatic Cancer.
J Clin Oncol. 2024 Sep 10;42(26):3067-3070. doi: 10.1200/JCO.24.00846. Epub 2024 Jul 11.
2
Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies.
Pathol Res Pract. 2019 Dec;215(12):152691. doi: 10.1016/j.prp.2019.152691. Epub 2019 Oct 17.
3
Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccine.
J Immunother Cancer. 2025 Jul 31;13(7):e011426. doi: 10.1136/jitc-2024-011426.
4
Q&A: Evidence presenter. Interview by Marian Turner.
Nature. 2013 Dec 19;504(7480):S9. doi: 10.1038/504S9a.
5
Dendritic cell-based cancer immunotherapy for pancreatic cancer.
Arab J Gastroenterol. 2018 Mar;19(1):1-6. doi: 10.1016/j.ajg.2017.05.013. Epub 2018 Mar 8.
6
Targeting dendritic cells to drive PDAC immunotherapy response.
Trends Pharmacol Sci. 2024 Dec;45(12):1095-1096. doi: 10.1016/j.tips.2024.10.009. Epub 2024 Nov 6.
7
What is recent in pancreatic cancer immunotherapy?
Biomed Res Int. 2013;2013:492372. doi: 10.1155/2013/492372. Epub 2012 Dec 26.
8
Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic Cancer.
J Clin Oncol. 2024 Sep 10;42(26):3083-3093. doi: 10.1200/JCO.23.02585. Epub 2024 Jul 1.
9
Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
Hum Vaccin Immunother. 2014;10(11):3354-68. doi: 10.4161/hv.34392.
10
Immunotherapy synergizes with chemotherapy targeting pancreatic cancer.
Immunotherapy. 2012 Jan;4(1):5-7. doi: 10.2217/imt.11.150.
本文引用的文献
1
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial.
Nat Med. 2024 Feb;30(2):531-542. doi: 10.1038/s41591-023-02760-3. Epub 2024 Jan 9.
2
Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer.
Cancer Immunol Res. 2023 Aug 3;11(8):1055-1067. doi: 10.1158/2326-6066.CIR-21-0946.
3
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.
Nature. 2023 Jun;618(7963):144-150. doi: 10.1038/s41586-023-06063-y. Epub 2023 May 10.
4
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.
JAMA Oncol. 2022 Nov 1;8(11):1571-1578. doi: 10.1001/jamaoncol.2022.3829.
5
Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I study.
Eur J Cancer. 2022 Jul;169:20-31. doi: 10.1016/j.ejca.2022.03.015. Epub 2022 Apr 28.
6
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.
J Clin Oncol. 2022 Apr 10;40(11):1220-1230. doi: 10.1200/JCO.21.02233. Epub 2022 Jan 27.
7
Open-label, Phase I Study of Nivolumab Combined with -Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer.
Clin Cancer Res. 2020 Sep 15;26(18):4814-4822. doi: 10.1158/1078-0432.CCR-20-0099. Epub 2020 Jun 18.
8
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer.
Cancer Cell. 2020 Mar 16;37(3):289-307.e9. doi: 10.1016/j.ccell.2020.02.008.
9
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4 T Cell Immunity.
Cell. 2019 Apr 18;177(3):556-571.e16. doi: 10.1016/j.cell.2019.02.005. Epub 2019 Apr 4.
10
Specialized dendritic cells induce tumor-promoting IL-10IL-17 FoxP3 regulatory CD4 T cells in pancreatic carcinoma.
Nat Commun. 2019 Mar 29;10(1):1424. doi: 10.1038/s41467-019-09416-2.
Zotero 插件